Transdermal Patches: Global Markets

Report Code: PHM273A

Publish Date: May 2023

Publisher: BCC Publishing

Category: Pharmaceuticals

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for transdermal patches is estimated to increase from $6.7 billion in 2022 to reach $8.8 billion by 2027, at a compound annual growth rate (CAGR) of 5.6% from 2022 through 2027.

Report Includes

  • 122 data tables and 53 additional tables
  • An overview of the global transdermal patches market
  • Estimation of the market size and analyses of global market trends, with data from 2019-2022, with projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the current and future market potential and quantification of transdermal patches market based on type, design, technology, application, and region
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
  • Analysis of transdermal patches pipeline products with focus on promising pipeline molecules/ drugs in development, and coverage of technological advances, scientific discoveries, and new therapies
  • Detailed analysis of the regulatory framework and policies, and snapshot of transdermal drug delivery system
  • Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies and a relevant patent analysis
  • Comprehensive company profiles of the leading players of the industry, including GlaxoSmithKline, Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan Pharmaceuticals inc. (Viatris), Novartis and Teva Pharmaceutical Industries Ltd.

Report Scope

This report aims to provide a comprehensive study of the global market for transdermal patches. It provides a detailed description of the different types of transdermal patch products and technology, as well as their current and historical market revenues.

Transdermal patches can be separated by their differing designs and technology, along with their applications. Transdermal patch technologies include matrix, reservoir, and other transdermal drug delivery technologies/systems.

This report also covers a detailed study of therapeutic applications of transdermal drug delivery, including pain, central nervous system disorders, hormonal applications, smoking cessation, motion sickness, cardiovascular disorders, and others. This in-depth analysis of the global market for transdermal patches includes historical data and market projections for sales segment by technology/system type, product, application, design, and region.

For in-depth understanding of the market, profiles of market participants, key marketed products, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global transdermal drug delivery technologies/devices market.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $6.4 billion
Market size forecast $8.8 billion
Growth rate CAGR of 5.6% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered technology, application, design, region, and country
Regions covered North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW)
Countries covered U.S., Mexico, Canada, France, Germany, U.K., Italy, Spain, China, India, Japan, Australia, Middle East, Africa and South America, GCC Countries, Argentina, and Brazil
Key Market Drivers
  • Aging Global Population
  • Developments in Transdermal Patch Design
  • Increase in Modern Lifestyle and Chronic Diseases
  • Emerging Non-opioid Drugs for Pain
  • Management and Hormonal Treatment
  • Rise in Awareness Programs on Transdermal Patches
Companies studied
JOHNSON & JOHNSON SERVICES INC.ABBVIE INC.
ALVOGENICURE PHARMA INC.
HISAMITSU PHARMACEUTICAL CO. INC.PERRIGO CO. PLC
PURDUE PHARMA L.P.TEVA PHARMACEUTICAL INDUSTRIES LTD.
AMNEAL PHARMACEUTICALS INC.SPARSHA PHARMA INTERNATIONAL PVT. LTD.
NOVARTIS AGLUYE PHARMA GROUP LTD.
LAVIPHARM S. A.BAYER AG
BAUSCH HEALTH COMPANIES INC.ENDO PHARMACEUTICALS INC.
GSK PLC.VIATRIS INC.
GRUNENTHAL GMBH
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The transdermal patches market is projected to grow from $6.4 billion in 2021 to $8.8 billion in 2027, at a compound annual growth rate (CAGR) of 5.6% during the forecast period.
The key factors driving the growth of Transdermal patches market includes
  • Growing incidence of chronic disease and infectious diseases
  • Emerging Non-opioid Drugs for Pain Management and Hormonal treatment
  • Aging Global Population Developments in Transdermal Patch Design
The Transdermal patches market is segmented based on technology, product, application, design and region.
Single-layer Drug Patch segment will dominate the market by the end of 2027.
North America holds the highest share in the market.
Key companies in the market includes
  • GSK plc
  • Mylan Pharmaceuticals inc.(Viatris)
  • Hisamitsu Pharmaceutical
  • Novartis
  • Johnson & Johnson
  • Teva Pharmaceutical
  • Endo Pharmaceuticals
  • AbbVie Inc.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Transdermal Patches: Global Markets262Free
Chapter- 1: Introduction9Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market Overview22Free
Chapter- 4: Market Dynamics14Free
Chapter- 5: Impact of COVID-19 on Pharma Industry6Free
Chapter- 6: Emerging Technology in Transdermal Patches5Free
Chapter- 7: Global Market for Transdermal Patches by Product Type10Free
Chapter- 8: Global Market for Transdermal Patches by Design4Free
Chapter- 9: Global Market for Transdermal Patches by Technology4Free
Chapter- 10: Global Market for Transdermal Patches by Application6Free
Chapter- 11: Global Market for Transdermal Patches by Region134Free
Chapter- 12: Competitive Landscape6Free
Chapter- 13: Company Profiles39Free

Related Reports

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Apr 2022 | Publisher - BCC Publishing | Code - HLC239B

The global market for chronic disease management therapeutics anddevice technologies should grow from $391.8 billion in 2021 to $553.0 billion by 2026, at compound annual growth rate (CAGR) of 7.1% for the period of 2021-2026.

Transdermal Drug Delivery: Global Markets

Published - Jul 2021 | Publisher - BCC Publishing | Code - PHM254A

The global market for transdermal drug delivery systems should grow from $6.4 billion in 2021 to $7.8 billion by 2026, at compound annual growth rate (CAGR) of 4.2% for the period of 2021-2026.

Topical Pain Relief Market

Published - May 2021 | Publisher - BCC Publishing | Code - PHM250A

The global topical pain management drugs market should reach $12.5 billion by 2025 from $9.1 billion in 2020 at a compound annual growth rate (CAGR) of 6.6% for the forecast period of 2020 to 2025.

Recent Reports

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Chagas Disease: American trypanosomiasis Market

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM282A

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Transdermal Patches: Global Markets
Sample Report